ELVN logo

ELVN

Enliven Therapeutics, Inc.NASDAQHealthcare
$38.83+2.75%ClosedMarket Cap: $2.32B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

22

Sales

26

Buy/Sell Ratio

0.85

Total Bought

$0.00

Total Sold

$21.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Mar 27Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell40,000$35.1025,000
Fri Mar 27Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell40,000$2.48136,268
Thu Mar 19Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell5,000$2.48176,268
Thu Mar 19Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell5,000$27.7625,000
Wed Mar 11Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell10,129$30.1925,000
Wed Mar 11Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell29,871$30.0225,000
Wed Mar 11Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell10,129$2.48181,268
Wed Mar 11Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell29,871$2.48191,397
Tue Mar 10Hohl Benjaminofficer: CHIEF FINANCIAL OFFICERSell10,000$29.5851,000